Simon Bott
-
- Prostate Cancer Diagnosis and Treatment 33
- Prostate Cancer Treatment and Research 32
- Renal cell carcinoma treatment 2
- Rheumatology top 5%
- Urologic and reproductive health conditions 15
- Urology top 5%
- Urinary Bladder and Prostate Research 3
-
- Bladder and Urothelial Cancer Treatments 7
- Genital Health and Disease 3
-
- MRI in cancer diagnosis 2
- Co-authors
- M C ParkinsonMagali WilliamsonAlex FreemanMartin YoungM.J. KellettHashim U. AhmedStephen LangleyManit Arya
- Journals
- British Journal of Urology (13 papers)Prostate Cancer and Prostatic Diseases (4 papers)Postgraduate Medical Journal (2 papers)
- Partner nations
- United KingdomFranceEgypt
In The Last Decade
Simon Bott
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 994
- Rheumatology 353
- Urology 108
- Cancer Research 118
- Oncology 188
Countries citing papers authored by Simon Bott
This map shows the geographic impact of Simon Bott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Bott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Bott more than expected).
Fields of papers citing papers by Simon Bott
This network shows the impact of papers produced by Simon Bott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Bott. The network helps show where Simon Bott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simon Bott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 29 | |
| 2 | 2017 | 28 | |
| 3 | 2014 | 66 | |
| 4 | 2011 | 53 | |
| 5 | 2010 | 98 | |
| 6 | 2008 | 34 | |
| 7 | 2007 | 127 | |
| 8 | 2006 | 7 | |
| 9 | 2006 | 82 | |
| 10 | 2006 | 95 | |
| 11 | 2005 | 12 | |
| 12 | 2005 | 36 | |
| 13 | 2004 | 78 | |
| 14 | 2004 | 18 | |
| 15 | 2004 | 4 | |
| 16 | 2004 | 45 | |
| 17 | 2003 | 4 | |
| 18 | 2002 | 16 | |
| 19 | 2002 | 144 | |
| 20 | 2002 | 1 |
About Simon Bott
Simon Bott is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (33 papers), Prostate Cancer Treatment and Research (32 papers), Urologic and reproductive health conditions (15 papers), Bladder and Urothelial Cancer Treatments (7 papers), Genital Health and Disease (3 papers), Urinary Bladder and Prostate Research (3 papers), MRI in cancer diagnosis (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (994 citations), Rheumatology (353 citations) and Urology (108 citations). Simon Bott has collaborated with scholars based in United Kingdom, France and Egypt. Frequent co-authors include M C Parkinson, Magali Williamson, Alex Freeman, Martin Young, M.J. Kellett, Hashim U. Ahmed, Stephen Langley, Manit Arya, Roger Kirby and Mark Emberton. Their work appears in journals such as British Journal of Urology, Prostate Cancer and Prostatic Diseases, Postgraduate Medical Journal, Surgical Oncology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.